ATRC AtriCure, Inc.
AtriCure, Inc. (ATRC) is expected to report earnings on November 2, 2026, after the market close. The consensus earnings estimate is $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +52.9% since its last earnings release on July 23, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About AtriCure, Inc.
AtriCure Inc is a medical device company. It develops, manufactures and sells cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue.
Sector
Healthcare
Industry
Medical Instruments/Supply